The expression of low molecular weight protein tyrosine phosphatase is up-regulated in 1,2-dimethylhydrazine-induced colon tumours in rats

International Journal of Cancer

Volumn 122, Issue 7, 2008, Pages 1675-1678

  Marzocchini, Riccardo ^a   Malentacchi, Francesca ^a   Biagini, Massimiliano ^a   Cirelli, Domenico ^a   Luceri, Cristina ^a   Caderni, Giovanna ^a   Raugei, Giovanni ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

Author keywords

1,2 dimethylhydrazine; Adenocarcinomas; Adenomas; Colon cancer; Low molecular weight protein tyrosine phosphatase

Indexed keywords

1,2 DIMETHYLHYDRAZINE; PROTEIN TYROSINE PHOSPHATASE; CARCINOGEN;

ADENOCARCINOMA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARCINOGENESIS; COLON CANCER; COLON TUMOR; HISTOPATHOLOGY; MALE; MOLECULAR WEIGHT; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; UPREGULATION; ANIMAL; CHEMICALLY INDUCED DISORDER; ENZYMOLOGY; FISCHER 344 RAT; GENE EXPRESSION REGULATION; METABOLISM;

1,2-DIMETHYLHYDRAZINE; ADENOCARCINOMA; ANIMALS; CARCINOGENS; COLONIC NEOPLASMS; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; MALE; MOLECULAR WEIGHT; PROTEIN TYROSINE PHOSPHATASES; RATS; RATS, INBRED F344; UP-REGULATION;

EID: 39649097851     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.23266     Document Type: Article

References (21)

1. Van der GP, Hunter T, Lindberg RA. Receptor protein-tyrosine kinases and their signal transduction pathways. Annu Rev Cell Biol 1994;10:251-337.
2. Cance WG, Liu ET. Protein kinases in human breast cancer. Breast Cancer Res Treat 1995;35:105-14.
3. Kopreski MS, Witters L, Brennan WA, Jr, Buckwalter EA, Chinchilli VM, Demers LM, Lipton A. Protein tyrosine kinase activity in breast cancer and its relation to prognostic indicators. Anticancer Res 1996;16:3037-41.
4. Lower EE, Franco RS, Miller MA, Martelo OJ. Enzymatic and immunohistochemical evaluation of tyrosine phosphorylation in breast cancer specimens. Breast Cancer Res Treat 1993;26:217-24.
5. Zhang ZY, Dixon JE. Protein tyrosine phosphatases: mechanism of catalysis and substrate specificity. Adv Enzymol Relat Areas Mol Biol 1994;68:1-36.
6. Raugei G, Ramponi G, Chiarugi P. Low molecular weight protein tyrosine phosphatases: small, but smart. Cell Mol Life Sci 2002;59:941-9.
7. Chiarugi P, Cirri P, Raugei G, Camici G, Dolfi F, Berti A, Ramponi G. PDGF receptor as a specific in vivo target for low MW phosphotyrosine protein phosphatase. FEBS Lett 1995;372:49-53.
8. Kikawa KD, Vidale DR, Van Etten RL, Kinch MS. Regulation of the EphA2 kinase by the low molecular weight tyrosine phosphatase induces transformation. J Biol Chem 2002;277:39274-9.
9. Parri M, Buricchi F, Taddei ML, Giannoni E, Raugei G, Ramponi G, Chiarugi P. Related articles, Links EphrinA1 repulsive response is regulated by an EphA2 tyrosine phosphatase. J Biol Chem 2005;280:34008-18.
10. Taddei ML, Chiarugi P, Cirri P, Buricchi F, Fiaschi T, Giannoni E, Talini D, Cozzi G, Formigli L, Raugei G, Ramponi G. Beta-catenin interacts with low-molecular-weight protein tyrosine phosphatase leading to cadherin-mediated cell-cell adhesion increase. Cancer Res 2002;62:6489-99.
11. Chiarugi P, Taddei ML, Schiavone N, Papucci L, Giannoni E, Fiaschi T, Capaccioli S, Raugei G, Ramponi G. LMW-PTP is a positive regulator of tumor onset and growth. Oncogene 2004;23:3905-14.
12. Malentacchi F, Marzocchini R, Gelmini S, Orlando C, Serio M, Ramponi G, Raugei G. Up-regulated expression of low molecular weight protein tyrosine phosphatases in different human cancers. Biochem Biophys Res Commun 2005;334:875-83.
13. Chang WW. Histogenesis of colon cancer in experimental animals. Scand J Gastroenterol Suppl 1984;104:27-43.
14. Morson BC. General overview of gastrointestinal precancer. Eur J Cancer Prev 1993;2(Suppl 2):5-8.
15. Jass JR. Classification of colorectal cancer based on correlation of clinical, morphological and molecular features. Histopathology 2007;50:113-30.
16. Wong L, Hawkins NJ, Ward RL. Colorectal cancer: a model for epigenetic tumorigenesis. Gut 2007;56:140-8.
17. Hong MY, Chapkin RS, Morris JS, Wang N, Carroll RJ, Turner ND, Chang WC, Davidson LA, Lupton JR. Anatomical site-specific response to DNA damage is related to later tumor development in the rat azoxymethane colon carcinogenesis model. Carcinogenesis 2001;22:1831-5.
18. Cheng X, Chen VW, Steele B, Ruiz B, Fulton J, Liu L, Carozza SE, Greenlee R. Subsite-specific incidence rate and stage of disease in colorectal cancer by race, gender, and age group in the United States, 1992-1997. Cancer 2001;92:2547-54.
19. Glebov OK, Rodriguez LM, Nakahara K, Jenkins J, Cliatt J, Humbyrd CJ, De Nobile J, Soballe P, Simon R, Wright G, Lynch P, Patterson S, et al. Distinguishing right from left colon by the pattern of gene expression. Cancer Epidemiol Biomarkers Prev 2003;12:755-62.
20. Iacopetta B. Are there two sides to colorectal cancer? Int J Cancer 2002;101:403-8.
21. Fang WB, Brantley-Sieders DM, Parker MA, Reith AD, Chen J. A kinase-dependent role for EphA2 receptor in promoting tumor growth and metastasis. Oncogene 2005;24:7859-68.